A prospective study was undertaken on the incidence of intrauterine infections by screening 1302 cord blood samples for total IgM by radial immunodiffusion. Specific IgM against cytomegalovirus (CMV), rubella and Toxoplasma were estimated in cord blood samples found to contain total IgM > 20 mg/dl. All these neonates were examined at birth and at discharge. Cord blood samples with total IgM > 20 mg/dl were further screened for specific IgM against rubella, CMV and Toxoplasma. Neonates found to have positive specific IgM were followed-up for hearing, opthalmological and developmental assessment. Raised cord blood (IgM > 20 mg/dl) was found in 270/1302 (20.6 per cent). Mean birth weight was comparable in babies with raised ( > 20 mg/dl) or low ( < 20 mg/dl) cord blood total IgM. Incidence of prematurity and low birth weight were not statistically different in babies with raised cord blood IgM when compared to those with low cord blood IgM levels. Similarly, incidence of intrauterine growth retardation (IUGR) idiopathic was similar in two groups. Specific IgM for rubella was found to be positive in eight (0.6 per cent). Of these, three had symptomatic rubella infection. Two mothers of these symptomatic babies had exanthematous viral illness during first trimester. Specific IgM for CMV was found to be positive in 23 (1.8 per cent) while two infants had symptomatic CMV disease. None of the babies was found to have specific IgM against Toxoplasma. One baby with symptomatic CMV disease and one with rubella died. Another baby with symptomatic CMV disease developed neonatal hepatitis which improved on follow-up but the infant went on to develop sensorineural deafness. All other asymptomatic babies with specific IgM positive against rubella and CMV were found to have normal vision, hearing and development on follow-up.
Introduction
The estimation of immunoglobulin levels in cord sera is important in detecting clinically inapparent intrauterine infections in neonates.
1 Elevated (>20 mg/dl) levels of IgM in cord blood suggest possible intrauterine infection. 2 IgM antibody is present in a concentration of 5-25 per cent of normal adult values in cord blood. 3 Serum IgM increases from a mean of 6 mg/dl at 28 weeks to 11 mg/dl at term. IgG is selectively transferred across the placenta from the mother to the fetus 4 while IgM and IgA are either completely absent from umbilical cord serum or present in small amounts. 5¹7 In neonates with intrauterine infection due to cytomegalovirus (CMV) and rubella the demonstration of virus specific IgM antibody is considered as definite evidence of intrauterine viral infection. 8;9 But many infants with congenital infections have normal IgM levels. Due to limited resources available with us, an attempt was made to look for specific IgM against CMV, rubella and Toxoplasma in cord blood samples with elevated cord blood IgM levels only.
Materials and Methods

Study population
A total of 1302 cord blood samples of liveborn babies were collected at the All India Institute of Medical Science (AIIMS) Hospital, New Delhi, during the period of study from October 1992 to September 1994. These 1302 mother-neonate dyads formed the study population for the estimation of incidence, clinical spectrum and outcome of intrauterine infection with CMV, rubella and Toxoplasma.
Cohort of neonates with raised cord blood specific IgM antibodies
Of the 1302 cord blood samples, 270 samples were found to have elevated total IgM levels of >20 mg/dl. Of these, 23 babies had specific IgM against CMV and eight babies against rubella. These 31 babies with specific IgM formed the cohort which was studied for clinical manifestations and outcome.
Examination of mothers
All enrolled mothers were subjected to regular antenatal evaluation. Apart from clinical examination, basic investigations (Hb, blood groups, urinary albumin/sugar) were undertaken in all the mothers. Other investigations such as ultrasound, urinary oestriol, glucose tolerance test etc., were undertaken as and when considered necessary by the treating obstetrician. Detailed maternal history with special reference to any antenatal infective illness (fever, rash, lymphadenopathy), toxoplasmosis, rubella, cytomegalovirus, herpes (TORCH) titres and history of previous stillbirths, abortions and neonatal deaths were recorded.
Newborn babies
The newborn babies were examined carefully by the paediatrician after ensuring adequate resuscitation. Birth weight was recorded. Gestational age was calculated from the last menstrual period (LMP) and in case of doubt, standard gestational age assessment was carried out by taking into account physical and neurological criteria. Neonates were classified into three intrauterine growth categories: appropriate-for-dates, small-for-dates, and large-for-dates. Neonatal problems were managed according to newborn intensive case unit (NICU) protocols at AIIMS by the treating team of the newborn unit.
Cord blood samples
Cord blood samples were collected in special vials and stored at 4ЊC. Next day the serum was separated out and stored in deep freeze at ¹20ЊC. Estimation of total IgM was carried out in batches of 96 samples by radial immunodiffusion technique. Samples containing cord blood IgM of >40 mg/dl were analysed further for the presence of IgA antibodies (to exclude contamination of cord blood by maternal blood).
Cord blood samples found to contain total IgM of >20 mg/dl were analysed by m-capture ELISA to detect specific IgM against CMV, rubella and Toxoplasma using commercial kits supplied by Organon Tenika (Infar).
Follow-up of cases after discharge
Subjects who survived the newborn period with positive specific IgM were followed-up in the High-Risk Neonates Clinic. Detailed clinical examination including anthropometery were performed at 6, 9 and 12 months (Ϯ 2 weeks). Hearing evaluation was carried out by auditory brainstem evoked responses (ABER) and behavioural audiometery. Multiple detailed ophthalmological examinations including fundoscopy were carried out at follow-up. They were subjected to systematic evaluation of mental, motor and social development by a clinical psychologist. The Bayley Scale of Infant Development (BSID), as modified for Indian children by Dr P. Pathak (1986), was administered by a trained clinical psychologist to assess mental and motor quotient. Using the deviation motor quotients (DMQ) and deviation mental quotients (DMeQ) as worked out by Dr Pathak, scores were assigned to our subjects. A deviation of mental or motor quotient under 70 was considered abnormal.
For social development, the Vineland Social Maturity Scale (standard for Indian children by Malin) was used to calculate the social quotient. An SQ of less than 70 was considered abnormal.
Statistical analysis
Statistical analysis of the data was done using Microsoft software on an IBM compatible PC/XT. Statistical analysis was carried out by using chi-squared test and normal test.
Results
Incidence
A total of 1302 neonates were prospectively recruited into the study. There were three pairs of twins and 1296 were singletons. Of these, 270 (20.6 per cent) babies were found to have cord blood total IgM of >20 mg/dl. The incidence of raised cord blood IgM level (>20 mg/dl) among term and preterm neonates was 21.6 per cent (227/1104) and 21.7 per cent (43/198), respectively. Characteristics of the neonates with raised cord blood IgM (>20 mg/dl) are shown in Table 1 .
Cord blood samples containing IgM > 20 mg/dl were analysed for specific IgM. Specific IgM against CMV was found to be positive in 23/1302 while specific IgM against rubella was found to be positive in 8/1302. None of the cord blood samples were found to have specific IgM against Toxoplasma. Clinical characteristics of newborns with positive specific IgM are shown in Table 2 . Neonates with raised IgM were not found to be at a higher risk of developing major or minor morbidities than babies with low IgM < 20 mg/dl (Table 3) .
Congenital malformations
A total of four babies with raised IgM levels were found to have major congenital malformations at birth. These included one case each of diaphragmatic hernia, dysplastic kidneys, CTEV, and cleft palate. Of the four, one baby died due to a diaphragmatic hernia and another died with dysplastic kidneys.
Sepsis
Clinical sepsis was suspected in 26 neonates and of these 15 were culture positive. Early onset clinical sepsis was diagnosed in 8/26 (30.7 per cent) babies and of these, four infants were blood culture positive.
Neonatal mortality
Twelve babies died during newborn period giving an overall neonatal mortality rate of 9.2 per 1000 live births.
Mortality among preterm and term infants was 4.2 per cent (eight babies) and 0.4 per cent (four babies), respectively. Major primary causes of death were immaturity (four babies), sepsis (three babies), malformations (two babies), hypoxia (one baby) and hydrops (two babies).
Three babies died due to infections. One of them died due to late-onset bacterial sepsis acquired in the NICU. Another death was of a preterm born at 32 weeks with a birth weight of 1.6 kg to a mother with a history of rubella infection during the first trimester. The baby was noticed to have hepato-splenomegaly, cataract, microophthalamia and periostitis. Cord blood IgM was noted to be 55 mg/dl with specific IgM positive for rubella (a report was available after death). The baby died at the age of 31 days due to respiratory failure. The third death was due to infection of a premature baby born at 29 weeks of gestation with a birth weight of 1.1 kg. The baby developed respiratory distress and chronic lung disease (BPD) due to prolonged assisted ventilation. The baby had hepato-splenomegaly and penumonitis with cord blood IgM 44 mg/dl and IgM antibodies positive for CMV. Urine examination showed inclusion granules in the epithelial cells. Prior to death, the baby received ganciclovir treatment for 8 days. Clinical features of the symptomatic babies are as shown in Tables 4 and 5 .
Follow-up
Twenty-four neonates with positive specific IgM were followed-up for a period of 6 months to 1 year, while five babies were lost to follow-up. Two babies died during hospital stay. One baby with symptomatic CMV disease developed sensori-neural deafness. This baby also had neonatal hepatitis which improved over a period of 4 months. Of the 23 asymptomatic babies (18 with CMV IgM and five with rubella IgM), none were found to have neuromotor retardation at follow-up. They had normal hearing and fundus examination (Table 6) . Discussion Prospective screening of cord blood serum by radial immunodiffusion technique revealed that 20.6 per cent (270/1302) of cord blood samples had elevated levels of IgM antibody > 20 mg/dl. In 70 neonates, total IgM levels were found to be > 40 mg/dl. Birthweight and weight for gestational age were comparable in neonates with a cord blood IgM level of more than or less than 20 mg/dl. An earlier study by Chandra et al. 10 found a positive correlation between the IgG or IgM level in the cord sera and birthweight, while another study by Seth et al. 11 found no correlation between IgG antibodies or IgM and birthweight. Incidence of prematurity and low birthweight was not significantly different in babies having cord blood IgM levels of less than or more than 20 mg/dl.
The high incidence of grossly raised cord blood IgM (> 40 mg/dl) may have been due to the presence of nonspecific IgM (e.g. rheumatoid factor); this is well reported in the literature. Contamination by maternal blood is reported to occur which is indicated by demonstrating cord blood serum IgA level, which is not passed transplacentally. It is unlikely, that maternal blood contamination might have resulted in a raised IgM level because all blood samples having a total IgM level > 40 mg/dl were found to have insignificant amount of IgA antibodies. Early onset clinical sepsis did not occur frequently in babies with raised cord blood IgM levels thus indicating that in-utero bacterial infection was not a possible reason. Neonatal morbidities (major and minor) were comparable in neonates with cord blood IgM levels of more or less than 20 mg/dl. Earlier studies have reported a higher prevalence of raised specific IgM against rubella and CMV in babies with congenital malformations. 12 The technique of m-capture IgM ELISA was used to detect specific IgM against CMV. This method has a specificity of 95 per cent and a sensitivity of approximately 70 per cent when testing congenitally infected neonates. Detection of specific IgM against CMV is diagnostic within 21 days of birth but may be absent in as many as 30 per cent of congenitally infected neonates. 13 In the present study, 23 neonates were found to have specific IgM against CMV in their cord blood. None of the mothers gave a history of viral illness during the antenatal period. Of these, two neonates had symptomatic CMV disease while 21 were asymptomatic. A similar incidence has been reported in the literature. The majority of CMV infections at birth are asymptomatic. cord blood indicates congenital infection, the incidence of congenital CMV infection in the present study is 1.8 per cent. Others have reported an incidence of 0.5-3 per cent. 15 There is no other data available from our country on the incidence of CMV disease in neonates at birth.
Urine specimens are commonly used for the isolation of CMV but the virus can be isolated from throat wash, blood or other specimens. In both the symptomatic neonates in our study the virus could be demonstrated by the shell-vial culture technique. Asymptomatic neonates were not evaluated for virus excretion because of technical logistics.
In eight babies specific IgM against rubella was found to be positive in the cord blood giving an incidence of 0.6 per cent. Of these, two mothers had a rubella infection during the first trimester and babies were found to be symptomatic at birth. One baby with a full blown picture of congenital rubella syndrome, and infection, died on day 31. The other baby had transient myocardial dysfunction with abnormal cardiac rhythm; the baby was normal at follow-up.
No history of viral infection was present in mothers of five asymptomatic babies who were positive for specific IgM for rubella. Another, symptomatic rubella infection was diagnosed in a newborn with cataract and congenital heart disease born to a mother who did not suffer from a viral infection in the antenatal period, but the baby's cord blood specific IgM was positive. Asymptomatic infection during pregnancy may occur in non-immune women while reinfection with rubella may occur both naturally acquired and vaccine induced protection. Reinfection is usually subclinical and it is detected serologically. Reinfection with rubella during pregnancy has been considered to carry a minimal risk to the fetus. 16 None of the cord blood samples with raised total IgM had specific IgM against Toxoplasma. It is important to keep in mind the geographical distribution of Toxoplasma infection. Congenital toxoplasmosis occurs in three to 10 children per 1000 births in France, where routine maternal screening is carried out, while in USA it is one per 19000 births. 17 Recognition of one or more clinical signs of the TORCH syndrome might be an indication for the diagnosis of congenital infection; such a policy has been called TORCH screening. 18;19 It appears that there is no routine screening of cord blood samples for the detection of intrauterine infection with CMV, rubella and Toxoplasma based on cord blood total IgM levels. One should estimate specific IgM based on clinical signs. A careful clinical examination of the infant with suspected congenital infection will generally lead the clinician to appropriate diagnostic tests.
